New Presentation

Investor Presentation

View our latest Investor Presentation to find the most recent investor-related information


Learn More

Company Overview

22nd Century Group, Inc. is a leading plant biotechnology company focused on technologies that alter the level of nicotine in tobacco plants and the level of cannabinoids in hemp/cannabis plants through genetic engineering, gene-editing and modern plant breeding. Our primary mission in tobacco is to reduce the harm caused by smoking by bringing our proprietary reduced nicotine content tobacco cigarettes – containing 95% less nicotine than conventional cigarettes – to adult smokers in the U.S. and international markets. Our primary mission in hemp/cannabis is to develop proprietary hemp/cannabis plants with valuable cannabinoid profiles and agronomic traits and to commercialize those plants through a synergistic portfolio of strategic partnerships in the hemp/cannabis industry.

Sign Up For Email Alerts

Receive updates straight into your inbox

Sign up today

Investor Contact Information

Company

22nd Century Group, Inc.
500 Seneca Street, Suite 507
Buffalo, NY 14204
T: 716-270-1523
Contact Us

Investor Relations

Mei Kuo
22nd Century Group, Inc.
Director, Communications & Investor Relations
500 Seneca Street, Suite 507
Buffalo, NY 14204
T: 716-300-1221
investorrelations@xxiicentury.com

Transfer Agent

Continental Stock and Transfer Company
1 State Street, 30th Floor
New York, NY 10004
T: 212-509-4000
cstmail@continentalstock.com